$700M BNB Move Fails to Save Windtree From Nasdaq Delisting

Windtree Therapeutics, a biotech steadfast that precocious announced a $700 cardinal BNB treasury strategy, has been delisted from Nasdaq for failing to conscionable a listing requirement. The BNB Inspired Rally and Subsequent Plunge Biotech institution Windtree Therapeutics, which announced a monolithic $700 cardinal BNB treasury move, has had its banal delisted from Nasdaq for failing […]